Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2175 of 3173 entries
View as:

Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00322517 Org: User:
Start: 04/30/06 End: 07/31/09 Due: 07/31/10

Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00106054 Org: User:
Start: 01/31/06 End: 09/30/06 Due: 09/30/07

Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01188759 Org: User:
Start: 05/31/12 End: 08/31/14 Due: 08/31/15

A Multicenter, Open Label Trial To Evaluate Pain Relief With Intravenous Followed By Oral Therapy With Parecoxib/Valdecoxib 40 Mg/Day For Treatment Of Post-Laparoscopic Surgery Pain

Phase: N/A Priority: Normal
NCT ID: NCT00660855 Org: User:
Start: 06/30/04 End: 07/31/04 Due: 07/31/05

To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.

Phase: N/A Priority: Normal
NCT ID: NCT00150423 Org: User:
Start: 01/31/01 End: 07/31/05 Due: 07/31/06

A Single-Radiolabeled Dose Mass Balance Study To Investigate The Absorption, Metabolism, And Excretion Of [14C] Palbociclib (PD-0332991) In Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01756768 Org: User:
Start: 01/31/13 End: 03/31/13 Due: 03/31/14

Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT00831415 Org: User:
Start: 03/31/09 End: 03/31/11 Due: 03/31/12

Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT00666276 Org: User:
Start: 02/28/07 End: 04/30/11 Due: 04/30/12

A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04707313 Org: User:
Start: 01/29/21 End: 10/11/23 Due: 10/11/24

Methods Study to Evaluate Use of Cardiac Ultrasound to Assess Heart Valve Abnormality in People.

Phase: N/A Priority: Normal
NCT ID: NCT00359489 Org: User:
Start: 04/30/07 End: 07/31/07 Due: 07/31/08

Safety and Efficacy of Benefix in Patients With Hemophilia B in Usual Care Settings in China

Phase: N/A Priority: Normal
NCT ID: NCT02336178 Org: User:
Start: 01/31/15 End: 08/31/16 Due: 08/31/17

Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00479258 Org: User:
Start: 10/31/07 End: 10/31/07 Due: 10/31/08

Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time

Phase: N/A Priority: Normal
NCT ID: NCT00809536 Org: User:
Start: 01/31/09 End: 02/28/09 Due: 02/28/10

Study Of Lybrel In Relation To Venous Thromboembolism

Phase: N/A Priority: Normal
NCT ID: NCT01297348 Org: User:
Start: 07/31/07 End: 04/30/12 Due: 04/30/13

The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00911235 Org: User:
Start: 05/31/09 End: 07/31/09 Due: 07/31/10

Relative Bioavailability and Food Effect Study

Phase: N/A Priority: Normal
NCT ID: NCT00827515 Org: User:
Start: 02/28/09 End: 05/31/09 Due: 05/31/10

A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark

Phase: N/A Priority: Normal
NCT ID: NCT05452798 Org: User:
Start: 02/01/22 End: 08/01/22 Due: 08/01/23

A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00557856 Org: User:
Start: 11/30/07 End: 03/31/13 Due: 03/31/14

Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA

Phase: N/A Priority: Normal
NCT ID: NCT02509026 Org: User:
Start: 09/24/15 End: 09/06/19 Due: 09/06/20

Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT01210482 Org: User:
Start: 08/24/10 End: 05/31/18 Due: 05/31/19

Arthroscopic Surgical Outcome Study In Subjects With Rotator Cuff Tears

Phase: N/A Priority: Normal
NCT ID: NCT00739947 Org: User:
Start: 10/13/08 End: 07/05/11 Due: 07/05/12

Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip

Phase: N/A Priority: Normal
NCT ID: NCT00864097 Org: User:
Start: 08/11/09 End: 11/24/10 Due: 11/24/11

INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus

Phase: N/A Priority: Normal
NCT ID: NCT01367457 Org: User:
Start: 01/31/11 End: 04/30/15 Due: 04/30/16

Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02458209 Org: User:
Start: 05/31/15 End: 12/31/15 Due: 12/31/16

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

Phase: N/A Priority: Normal
NCT ID: NCT00396448 Org: User:
Start: 02/28/07 End: 02/28/09 Due: 02/28/10